Adrenal insufficiency development during chemotherapy plus anti-programmed death receptor-1 monoclonal antibody (tislelizumab) therapy in patients with advanced gastric cancer: two case reports

Immune checkpoint inhibitor (ICI)-associated adrenal insufficiency is rare but may become a serious adverse event in patients treated with ICIs. The present case report documents two cases of adrenal insufficiency developed during chemotherapy plus tislelizumab (百泽安, Baize’an; BeiGene Ltd.) therapy...

Descripción completa

Detalles Bibliográficos
Autor principal: Baek, Jin Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Yeungnam Medical Science 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895967/
https://www.ncbi.nlm.nih.gov/pubmed/33866751
http://dx.doi.org/10.12701/yujm.2021.00934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895967/
https://www.ncbi.nlm.nih.gov/pubmed/33866751
http://dx.doi.org/10.12701/yujm.2021.00934

Ejemplares similares